Search Results 171-180 of 5724 for albumin

1. 5-strain Probiotic Formulation in Hormone Receptor-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss - Mayo Clinic

   Albumin ≥ 3 g/dL. Willing and able to provide research stool and blood samples. Negative serum pregnancy test done ≤ 7 days prior to enrollment, for women ...

2. Multiple Myeloma Clinical Trials - Mayo Clinic Research

   Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of cancer cells, either by ...

3. Vorinostat, Temozolomide, or Bevacizumab in Combination with Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients with Newly Diagnosed High-Grade Glioma - Mayo Clinic

   Serum albumin ≥ 2 g/dL; PT INR ≤ 1.5 times ULN; Not pregnant or nursing; Negative pregnancy test; Fertile patients must use effective contraception during all ...

4. A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) - Mayo Clinic

   Compensated NASH cirrhosis based on biopsy at screening of MAESTRO-NASH and baseline of MAESTRO-NAFLD-OLE, including Child Pugh-A (score 5-6), MELD <12, albumin ...

5. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   Calcium ≥ LLN (corrected for serum albumin, if albumin abnormal);; Magnesium ≥ LLN;; Sodium ≥ LLN;; Phosphorus ≥ LLN. NOTE: Supplementation may be given ...

6. Untitled

   Page 1.

7. Blood transfusion - Mayo Clinic

   A blood transfusion can help replace blood lost due to injury or surgery. It also can treat an illness that affects how well blood does its job.

8. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

   Albumin ≥ 3.0 g/dL. Patients known to be Human immunodeficiency virus (HIV)+ are permitted. Patients with CD4>200 and Serum HIV viral load of < 200 copies ...

9. Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis - Mayo Clinic

   Albumin < 3.5 g/dL. International normalized ratio (INR) ≥ 1.7. Current or history of significant alcohol consumption for a period of more than 3 ...

10. Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer - Mayo Clinic

    Albumin ≥ 2.8 g/dL; Serum creatinine ≤ 1.5 x ULN, OR calculated creatinine clearance ≥ 30 mL/minute (modified Cockcroft and Gault formula); Urine protein ...